We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current CGTX market cap is 61.14M. The company's latest EPS is USD -0.8478 and P/E is -2.36.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -12.63M | -9.3M | -8.97M | -11.82M | -14.75M |
| Net Income | -6.63M | -5.18M | -6.17M | -4.73M | -6.75M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -17.41M | -28.6M | -43.55M | -50.72M |
| Net Income | -12.07M | -16.25M | -21.4M | -25.79M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 53.56M | 50.43M | 45.66M | 43.96M | 38.77M |
| Total Liabilities | 14.24M | 10.18M | 9.88M | 9.57M | 9.85M |
| Total Equity | 39.32M | 40.25M | 35.78M | 34.39M | 28.93M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.12M | 59.14M | 50.43M | 35.16M |
| Total Liabilities | 19.93M | 7.86M | 10.18M | 10.69M |
| Total Equity | -68.18M | 51.27M | 40.25M | 24.47M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -8.35M | -18.53M | -2.71M | -6.4M | -10.56M |
| Investing | -161k | -171k | -41k | -59k | -117k |
| Financing | 404k | 5.55M | -10k | 2.09M | 2.08M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.43M | -3.63M | -18.53M | -16.02M |
| Investing | -10k | -27k | -171k | -147k |
| Financing | 5.77M | 53.2M | 5.55M | 4.52M |
| Market Cap | 61.14M |
| Price to Earnings Ratio | -2.36 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.03 |
| Price to Book Ratio | 2.49 |
| Dividend Yield | - |
| Shares Outstanding | 30.42M |
| Average Volume (1 week) | 83.77k |
| Average Volume (1 Month) | 126.62k |
| 52 Week Change | 25.63% |
| 52 Week High | 3.49 |
| 52 Week Low | 0.9001 |
| Spread (Intraday) | 0.26 (12.87%) |
| Company Name | Cognition Therapeutics Inc |
| Address |
2140 s dupont hwy camden, delaware 19934 |
| Website | https://www.cogrx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
